Atlas Trials

Glycation of apoA-I and Diabetic Atherogenesis

Clinical trial NCT05659043 · UNKNOWN

Trial details

NCT number
NCT05659043
Sponsor
Ruijin Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2017-01-01
Primary completion
2021-12-01
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.